Aleksandra Luginina, Anastasiia Gusach, Elizaveta Lyapina, Polina Khorn, Nadezda Safronova, Mikhail Shevtsov, Daria Dmitirieva, Dmitrii Dashevskii, Tatiana Kotova, Ekaterina Smirnova, Valentin Borshchevskiy, Vadim Cherezov, Alexey Mishin
Dihydroxy acid leukotriene (LTB4 ) and cysteinyl leukotrienes (LTC4 , LTD4 , and LTE4 ) are inflammatory mediators derived from arachidonic acid via the 5-lipoxygenase pathway. While structurally similar, these two types of leukotrienes exert their functions through interactions with two distinct G -protein-coupled receptor (GPCR) families, BLT and CysLT receptors, which share low sequence similarity and belong to phylogenetically divergent GPCR groups. Selective antagonism of leukotriene receptors has been proposed as a promising strategy for the treatment of many inflammation-related diseases including asthma and COPD, rheumatoid arthritis, cystic fibrosis, diabetes, and several types of cancer...
September 11, 2023: Journal of Biological Chemistry